Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-11 · accession 0001415889-24-029376 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-13 | 2024-12-11+ | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +40.0K | 31.0K | New | +$25.6K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | Dorsey Brian | COO | S - Sale+OE | $12.35 | -40.0K | 6,024 | -87% | -$494.0K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | Dorsey Brian | COO | M - OptEx | $0.00 | -40.0K | 46.8K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-11 | M | A | 15,000 | $0.64 | 21,024 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-11 | S | D | 15,000 | $12.43 | 6,024 | D | — | — | (F2) The weighted average sale price for the transaction report was $12.4284, and the range of prices were between $12.34 and $12.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2024-12-12 | M | A | 25,000 | $0.64 | 31,024 | D | — | — | |
| 4 | Common | Common Stock | 2024-12-12 | S | D | 25,000 | $12.30 | 6,024 | D | — | — | (F3) The weighted average sale price for the transaction report was $12.2973, and the range of prices were between $12.13 and $12.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-12-12 | M | D | 25,000 | $0.00 | 21,828 | D | $0.64 · — to 2028-11-28 | 25,000 Common Stock | (F4) Immediately exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-12-11 | M | D | 15,000 | $0.00 | 46,828 | D | $0.64 · — to 2028-11-28 | 15,000 Common Stock | (F4) Immediately exercisable. |